Table 1.
n | % | Median (range) | |
---|---|---|---|
Gender | |||
Female | 90 | 41.1 | |
Male | 129 | 58.9 | |
Age at RT [years] | 68 (6–91) | ||
Primary tumor type | |||
NSLC | 56 | 17.7 | |
CRC | 93 | 29.4 | |
Melanoma | 11 | 3.5 | |
Breast Cancer | 20 | 6.3 | |
Others | 136 | 43.0 | |
Number of pulmonary METs | |||
≤ 3 | 203 | 64.2 | |
> 3 | 113 | 35.8 | |
MET location | |||
Central | 34 | 10.8 | |
Upper lobe | 130 | 41.1 | |
Middle lobe | 23 | 7.3 | |
Lower lobe | 129 | 40.8 | |
Laterality | |||
Right | 169 | 53.5 | |
Left | 145 | 45.9 | |
Bilateral | 2 | 0.6 | |
Extra thoracic MET | |||
Yes | 131 | 41.5 | |
No | 185 | 58.5 | |
KPS [%] at RT | |||
100 | 8 | 2.5 | |
90 | 141 | 44.6 | |
80 | 137 | 43.4 | |
70 | 22 | 7.0 | |
60 | 7 | 2.2 | |
50 | 1 | 0.3 | |
Prior thorax RT | |||
Yes | 87 | 27.5 | |
No | 229 | 72.5 | |
CHT between MET diagnosis and SBRT | |||
Yes | 58 | 18.4 | |
No | 258 | 81.6 | |
Time primary diagnosis until MET diagnosis [months] | 30.9 (0–265.9) | ||
Time MET diagnosis until RT [months] | 1.7 (0–127.3) | ||
PTV [ml] | 28.8 (2.0–517.0) | ||
GTV [ml] | 5.4 (0.1–217.6) |
NSCLC Non-small cell lung cancer, CRC Colorectal carcinoma, KPS Karnofsky performance score, RT Radiotherapy, CHT Chemotherapy, MET Metastasis, PTV Planning target volume, GTV Gross tumor volume